Min-hsuan Lin
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies.
Journal: Microbiology and molecular biology reviews : MMBR
Published: May 06, 2026
Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy.
Journal: Molecular therapy. Nucleic acids
Published: June 13, 2024
Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Journal: Microbiology spectrum
Published: November 29, 2022
Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.
Journal: Communications biology
Published: June 24, 2020
Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
Journal: Viruses
Published: February 28, 2020
Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant.
Journal: mBio
Published: August 29, 2019
eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency.
Journal: Virology
Published: November 26, 2018
Study of epidemiological characteristics and viral sources of dengue fever outbreak in Guangxi Zhuang Autonomous Region, 2014
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: October 22, 2016
Binding of the eukaryotic translation elongation factor 1A with the 5'UTR of HIV-1 genomic RNA is important for reverse transcription.
Journal: Virology journal
Published: February 16, 2015
A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.
Journal: Journal of virology
Published: November 30, 2014
Last Updated: 09/26/2026